Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis

Clara Vigneron1, Frédéric Pène2, Julien Charpentier3

  • 1Service de médecine intensive-réanimation, Hôpital Cochin, AP-HP. Centre. 27 rue du Faubourg Saint Jacques, 75014 Paris, France; AP-HP. Centre - Université de Paris, 27 rue du Faubourg Saint Jacques, Paris 75014, France.

Autoimmunity Reviews
|August 3, 2022
PubMed

Insights

Systemic sclerosis (SSc) patients admitted to the ICU can experience severe, life-threatening cardiac dysfunction. While this cardiac dysfunction may be reversible, it is linked to a poor long-term prognosis for SSc patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Intensive Care Medicine

Background:

  • Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by fibrosis, vascular dysfunction, and immune dysregulation.
  • Cardiac involvement is a significant cause of morbidity and mortality in SSc patients.
  • Acute cardiac dysfunction in SSc patients admitted to the ICU is not well-characterized.

Purpose of the Study:

  • To describe the clinical presentation, management, and outcomes of SSc patients with acute cardiac dysfunction in the ICU.
  • To highlight the specific cardiac manifestations and their reversibility in this patient population.

Main Methods:

  • Retrospective study of SSc patients admitted to the ICU for acute cardiac dysfunction between 2012 and mid-2021.
  • Analysis of clinical data, cardiac biomarkers, electrocardiogram (ECG) findings, echocardiographic parameters, and treatment strategies.
  • Evaluation of patient survival during ICU stay and at 6 months post-discharge.

Main Results:

  • Nine female SSc patients were included, predominantly with diffuse SSc and digital ulcers.
  • Most patients presented with cardiac symptoms and ECG modifications, along with elevated troponin and Nt-pro-BNP levels.
  • Severe left ventricular ejection fraction (LVEF) impairment was observed, requiring intensive cardiovascular support; however, LVEF showed spontaneous improvement during ICU stay and returned to baseline within 6 months.
  • Seven patients (78%) survived the ICU stay, but only 4 (44%) were alive at 6 months.

Conclusions:

  • SSc patients can experience uncommon, severe, and life-threatening acute cardiac dysfunction in the ICU.
  • This cardiac dysfunction, though potentially reversible, is associated with a poor long-term prognosis.
  • Early recognition and management of cardiac dysfunction are crucial in SSc patients admitted to the ICU.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
36
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
42
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
40
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
29